Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Rheumatoid Arthritis
What is your approach to biologic therapy in older adults (80+) and CKD with RA?
Related Questions
Do you use the peri-operative management of biologics and DMARDs guidelines, which were mainly based on total hip and knee replacement surgeries, for all peri-operative surgical management?
When considering a biologic for seropositive RA after failure of methotrexate or triple therapy, do you consider using abatacept as a first line biologic or would prefer choosing TNFi?
Would you escalate therapy in a patient with rheumatoid arthritis without synovitis, but a new rheumatoid nodule?
Do you consider Anti-carbamylated protein antibodies (anti-CarP) as having any significance in evaluation of patients if RF and ACPA negative and clinically no active synovitis yet widespread arthralgias and generalized osteoarthritis?
What is the maximum dose of leucovorin that you use with methotrexate?
Do you generally find plain radiographs useful as part of your baseline evaluation in suspected rheumatoid arthritis?
How would you manage a patient with erosive seronegative rheumatoid arthritis with IgG and IgM deficiency?
How would you approach management of a patient with seropositive RA and UIP-ILD, with concern for active lung disease?
When do you recommend initiation of targeted therapies in active RA with history of malignancy?
What is your approach to assessing inflammatory arthritis flares in joints that have been replaced (such as knees)?
